3-Methylcholanthrene

3-Methylcholanthrene

SCHEMBL156129

Cc1ccc2cc3c(ccc4ccccc43)c3c2c1CC3

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 1.00
CYP1A2 P05177 4/20 1.00
MAPT P10636 4/20 1.00
FYN P06241 2/20 1.00
ACHE P22303 2/20 1.00
AHR P35869 2/20 1.00
LCK P06239 1/20 1.00
ADORA3 P0DMS8 1/20 1.00
SLC6A2 P23975 1/20 1.00
TSHR P16473 4/20 0.43
CYP2A6 P11509 3/20 0.43
HSD17B10 Q99714 5/20 0.42
HIF1A Q16665 2/20 0.42
CYP1B1 Q16678 1/20 0.42
HPGD P15428 5/20 0.41
HPRT1 P00492 3/20 0.41
RAB9A P51151 2/20 0.40
CYP3A4 P08684 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
ERBB2 P04626 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
3-Methylcholanthrene SCHEMBL29397062 1.00 ALDH1A1 (1.00) ALDH1A1CYP1A2MAPTFYNACHE
3-Methylcholanthrene SCHEMBL29444145 1.00 ALDH1A1 (1.00) ALDH1A1CYP1A2MAPTFYNACHE
3-Methylcholanthrene SCHEMBL2958054 0.98 ALDH1A1 (0.97) ALDH1A1CYP1A2MAPTFYNACHE
3-Methylcholanthrene SCHEMBL27621124 0.98 ALDH1A1 (0.97) ALDH1A1CYP1A2MAPTFYNACHE
3-Methylcholanthrene SCHEMBL8504132 0.80 ALDH1A1 (0.65) ALDH1A1CYP1A2MAPTFYNACHE
SCHEMBL8559924 0.80 ALDH1A1 (0.67) ALDH1A1CYP1A2MAPTFYNACHE
SCHEMBL3345975 0.80 CYP1A2 (0.67) ALDH1A1CYP1A2MAPTFYNACHE
SCHEMBL3345885 0.80 ALDH1A1 (0.67) ALDH1A1CYP1A2MAPTFYNACHE
Cholanthrene SCHEMBL9048 0.79 ALDH1A1 (0.65) ALDH1A1CYP1A2MAPTFYNACHE
SCHEMBL15992274 0.78 ALDH1A1 (0.63) ALDH1A1CYP1A2MAPTFYNACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2788 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119804072-B Method for efficiently extracting polycyclic aromatic hydrocarbon in sediment 同济大学 2025-05-27 CN claimed
CN-119804072-A Method for efficiently extracting polycyclic aromatic hydrocarbon in sediment 同济大学 2025-04-11 CN claimed
US-20250051430-A1 NEUTRALIZATION OF ACYL-COA BINDING PROTEIN CONFERS AUTOPHAGY-DEPENDENT ORGAN PROTECTION Institut National de la Santé et de la Recherche Médicale (FR) 2025-02-13 US claimed
EP-4475883-A1 NEUTRALIZATION OF ACYL-COA BINDING PROTEIN CONFERS AUTOPHAGY-DEPENDENT ORGAN PROTECTION Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) 2024-12-18 EP claimed
CN-118922206-A Neutralization of acetyl-CoA binding proteins confers autophagy-dependent organ protection 国家医疗保健研究所 2024-11-08 CN claimed
CN-118389440-A Murine gastric stromal tumor cell strain 暨南大学附属第一医院(广州华侨医院) 2024-07-26 CN claimed
CN-114982711-B Spontaneous tumor forming model of mouse gastric stromal tumor, construction method and application thereof 广东省人民医院 2023-11-10 CN claimed
WO-2023152637-A1 NEUTRALIZATION OF ACYL-COA BINDING PROTEIN CONFERS AUTOPHAGY-DEPENDENT ORGAN PROTECTION INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2023-08-17 WO claimed
CN-114965797-B Rapid detection method for 24 polycyclic aromatic hydrocarbons in complex cooked food matrix 广东工业大学 2023-08-08 CN claimed
CN-114982711-A Spontaneous tumor formation model of mouse gastromesenchyme tumor and construction method and application thereof 广东省人民医院 2022-09-02 CN claimed
US-5569585-A STIMULATING NON-RESTING IMMUNE CELLS TO ACTIVITY: STIMULANT DOSAGE WILL ACTIVATE PRIMED CELLS BUT DOES NOT STIMULATE RESTING CELLS; MEASUREMENT CELLCOR, INC. (US) 1996-10-29 US claimed
EP-0721463-A1 ENDOTHELIAL MONOCYTE ACTIVATING POLYPEPTIDE II: A MEDIATOR WHICH ACTIVATES HOST RESPONSE The Trustees of Columbia University in the City of New York (US) 1996-07-17 EP claimed
EP-0688223-A1 $i(IN VITRO) ASSAY MEASURING DEGREE OF ACTIVATION OF IMMUNE CELLS CELLCOR, INC (US) 1995-12-27 EP claimed
US-5466696-A Mixtures for treatment of alzheimer's disease WARNER LAMBERT COMPANY (US) 1995-11-14 US claimed
EP-0659082-A1 USE OF CYTOCHROME P450 INHIBITORS FOR INHIBITING THE METABOLISM OF NITROGEN SUBSTITUTED ACRIDINE WARNER-LAMBERT COMPANY (US) 1995-06-28 EP claimed
US-5422350-A Alzheimer's disease WARNER-LAMBERT COMPANY (US) 1995-06-06 US claimed
WO-1995009180-A1 ENDOTHELIAL MONOCYTE ACTIVATING POLYPEPTIDE II: A MEDIATOR WHICH ACTIVATES HOST RESPONSE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 1995-04-06 WO claimed
WO-1994020120-A1 IN VITRO ASSAY MEASURING DEGREE OF ACTIVATION OF IMMUNE CELLS CELLCOR, INC. (US) 1994-09-15 WO claimed
WO-1994005296-A2 USE OF CYTOCHROME P450 INHIBITORS FOR INHIBITING THE METABOLISM OF NITROGEN SUBSTITUTED ACRIDINE WARNER-LAMBERT COMPANY (US) 1994-03-17 WO claimed
US-4914032-A Process for the long-term surviving culture of hepatocytes CENTRO DE INVESTIGATION Y ESTUDIOS AVANZADOS DEL INSTITUTO POLITECNICO NACIONAL (MX) 1990-04-03 US claimed